All News

The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.

Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.

The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.

A study in Scotland found that multiple successive changes from originator infliximab to biosimilars effective and safe for patients with irritable bowel disease (IBD), irrespective of the number of switches (single, double, and triple).

A recent review studied the increased requests for telemedicine abortion care and decreased in-person visits to abortion clinics.

The expansion from Express Scripts offers increased reimbursement opportunities and creates an Independent Pharmacy Advisory Committee to expand the role of rural, suburban and urban pharmacies in the healthcare system.

RizaFilm is a different formulation of rizatriptan that has been changed into a film, meant to be taken orally and absorbed in mouth.

This comes after a district court in Texas ruled to keep Mifepristone available, but with heavy restrictions.

Data was presented at the 44th National Association of Pediatric Nurse Practitioners Conference regarding the effectiveness of vaccines and antivirals in preventing life threatening conditions.

At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.

HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.

Your weekly roundup of the latest news from Drug Topics®.

Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.

A recent study showed a link between menopause and increased glaucoma risk, with estrogen-based treatment being a possible solution.

Tirzepatide was associated with a greater reduction in hemoglobin A1c and body weight when compared to semaglutide. But with a current list price of $1,023 for a one-month supply, is tirzepatide (Mounjaro; Lilly) worth it?

A new survey found that neither generation is particularly good at maintaining healthy sun habits, and have low skin cancer awareness.

Researchers of a new study investigated what's causing vaccine hesitancy, and why individuals are feeling vaccine fatigue.

GrayMatters Health plans to use its technology for other mental health indications in the future.

A new study examines whether anakinra can reduce inflammation and the need for mechanical ventilation in patients with severe COVID-19 pneumonia.

The FDA granted the EUA based on the phase 3 trial results that demonstrated vilobelimab's efficacy compared to placebo, with a 23.9% relative reduction in all-cause mortality from COVID-19 at 28 days.

A new study from JAPHA explores the link between OUD and social factors.

The FDA, state governors, and OB/GYN groups around the country are fighting back against Judge Matthew Kacsmaryk’s ruling.

The drug, called Atovaquone, has been voluntarily recalled due to possible Bacillus cereus contamination.

The FDA has finally decided to withdraw approval of Makena and its generics after Covis Pharma volunteered to remove the drug from market in March.

Data reveal 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, leading authors of a survey to highlight the need for “urgent action” to maintain routine vaccination levels among children.

Approximately 8000 to 9000 U.S. patients would be eligible for this combination, intended for patients with locally advanced or metastatic urothelial cancer (la/mUC).

Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken over 3 years on average to complete since 2012.